Skip to main content
MAGN
NYSE Manufacturing

Magnera Posts $90M Q4 Operating Loss on $106M Impairment, Guides FY27 EBITDA to $390-410M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Neutral
Importance info
7
Price
$12.89
Mkt Cap
$444.994M
52W Low
$7.815
52W High
$15.524
52W Position info
65% above low
Off High info
17% below high
Rel. Volume info
2.8× avg
Market data snapshot near publication time

MAGN sits 65% above its 52-week low of $7.815 on elevated volume (2.8× avg).

Summary

Magnera's fiscal 2026 results show a $90 million Q4 operating loss driven by a $106 million impairment, but adjusted EBITDA rose 8% to $97 million and free cash flow hit $115 million. FY2027 guidance calls for $390-410 million of adjusted EBITDA.


Key Events · Earnings and Guidance · MAGN

  • Q4 Loss Driven by Impairment

    Net sales of $851 million produced a $90 million operating loss after a $106 million goodwill and other impairment charge; adjusted EBITDA was $97 million, up 8% year over year.

  • Full-Year Cash Generation Strong

    Fiscal 2026 operating cash flow of $178 million less $63 million of net capex left $115 million of free cash flow, and the company repaid $122 million of debt, bringing total debt to $1.85 billion.

  • FY2027 Guidance Issued

    Management guides to adjusted EBITDA of $390-410 million (about 6% growth at the $400 million midpoint versus $378 million actual) and free cash flow of $110-130 million.

  • Volume Weakness Offset by Pricing

    Q4 sales rose 1% as a $43 million pricing increase from raw-material pass-through offset a 4% organic volume decline, with soft healthcare demand in the Americas and general weakness in Europe.


Analysis · MAGN · Manufacturing

The quarter's headline loss is an accounting event, not an operating collapse: strip out the $106 million goodwill and other impairment and the business generated $97 million of adjusted EBITDA, up 8% year over year. Cash matters more here. Operations produced $178 million, funding $63 million of capex and $122 million of debt repayment, which left $115 million of free cash flow and brought debt down to $1.85 billion. Management's FY2027 guide of $390-410 million adjusted EBITDA implies roughly 6% growth at the midpoint, a modest step up that leans on Project CORE cost cuts and merger synergies rather than volume, since organic volumes fell 4% in the quarter. The risk is that the impairment signals the merger-carried goodwill is worth less than carried, and the prior 10-Q already flagged ineffective internal controls.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MAGN was trading at $12.89 on NYSE in the Manufacturing sector, with a market capitalization of approximately $445M. The 52-week trading range was $7.82 to $15.52. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MAGN - Latest Insights

MAGN
Nov 18, 2026, 4:31 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $11.91
Real-time Price: $12.89 info
Change: +$0.9803 (+8%) info
Market Cap: $444.994M info
MAGN
Aug 06, 2026, 4:58 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $12.53
Real-time Price: $12.89 info
Change: +$0.3603 (+3%) info
Market Cap: $444.994M info
MAGN
May 07, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.52
Real-time Price: $12.89 info
Change: +$1.37 (+12%) info
Market Cap: $444.994M info
MAGN
May 06, 2026, 6:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.10
Real-time Price: $12.89 info
Change: +$1.79 (+16%) info
Market Cap: $444.994M info
MAGN
Feb 05, 2026, 4:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.96
Real-time Price: $12.89 info
Change: -$2.07 (-14%) info
Market Cap: $444.994M info